PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33103445-6	2020	ACY-1215 treatment also suppressed phosphorylation of epidermal growth factor receptor (EGFR) and several signaling molecules associated with renal fibrogenesis, including AKT, signal transducer and activator of transcription 3 and nuclear factor kappa light chain enhancer of activated B cells in the injured kidney.	ricolinostat	0-8	thymoma viral proto-oncogene 1	Mus musculus	172-175	
30050135-0	2018	Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways.	ricolinostat	0-12	thymoma viral proto-oncogene 1	Mus musculus	127-130	
30050135-0	2018	Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways.	ricolinostat	14-22	thymoma viral proto-oncogene 1	Mus musculus	127-130	
30050135-5	2018	We further demonstrated that ACY-1215 treatment reduced the expression of PI3K, P-AKT, P-mTOR, and P-ERK1/2 and increased that of Ac-H3K9 and Ac-H4K8.	ricolinostat	29-37	thymoma viral proto-oncogene 1	Mus musculus	82-85	
30050135-10	2018	In conclusion, our study showed that ACY-1215 suppressed proliferation and promoted apoptosis in ESCC via miR-30d/PI3K/AKT/mTOR and ERK pathways and that ACY-1215 may be a promising antitumor agent in ESCC.	ricolinostat	37-45	thymoma viral proto-oncogene 1	Mus musculus	119-122	
34958116-6	2022	Furthermore, ACY-1215 displayed a synergistic effect with specific inhibitors of ATM, an activator of Akt, in inducing cancer cell apoptosis and inhibiting their motility.	ricolinostat	13-21	thymoma viral proto-oncogene 1	Mus musculus	102-105